Constellation Pharmaceuticals Announces First-Quarter 2021 Financial Results and Provides Business Update

NEXT STORY
Clearside Biomedical Announces Multiple Poster Presentations at the Association for Research in Vision and Ophthalmology 2021 Virtual Meeting
PREV STORY
G1 Therapeutics Initiates Randomized Double Blind Placebo Controlled Phase 2 Study of COSELA™ (trilaciclib) in Non-Small Cell Lung Cancer (PRESERVE 4)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AnaptysBio Announces Second Quarter 2018 Financial Results and Provides Pipeline Updates

Top-line Phase 2a Data from Etokimab (ANB020) in Eosinophilic Asthma Expected in Third Quarter ...

author_avatar
NASDAQ Market News

Abeona Therapeutics Announces Leadership Appointments with Max Colao as Chief Commercial Officer

NEW YORK and CLEVELAND, July 26, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO), ...

author_avatar
NASDAQ Market News

Orion Group Financial Statement documents 2017 and Corporate Governance Statement published

ORION CORPORATION           STOCK EXCHANGE RELEASE         26 FEBRUARY 2018 at 13.00 EET                       Orion Group ...

author_avatar
NASDAQ Market News